← back to search

Shaoyan Zhang

University of Alabama at Birmingham · US
Area of research
Pulmonary and Respiratory Medicine · Otorhinolaryngology
Research interest
Research interests include Cystic fibrosis, Medicine, Cystic fibrosis transmembrane conductance regulator, Pseudomonas aeruginosa, Mucociliary clearance, and Ivacaftor.
h-index
citations
446
works
19
NIH funding
primary concept
email

Recent publications

Hypoxia‐induced cystic fibrosis transmembrane conductance regulator dysfunction is a universal mechanism underlying reduced mucociliary transport in sinusitis
International Forum of Allergy & Rhinology 2023cited by 6position: middledoi
LPS decreases CFTR open probability and mucociliary transport through generation of reactive oxygen species
Redox Biology 2021cited by 21position: middledoi
Improvement cues of lesion absorption using the adjuvant therapy of traditional Chinese medicine Qinbudan tablet for retreatment pulmonary tuberculosis with standard anti-tuberculosis regimen
Infectious Diseases of Poverty 2020cited by 47position: firstdoi
Contribution of Short Chain Fatty Acids to the Growth of Pseudomonas aeruginosa in Rhinosinusitis
Frontiers in Cellular and Infection Microbiology 2020cited by 25position: middledoi
The impact of <i>Lactococcus lactis</i> (probiotic nasal rinse) co‐culture on growth of patient‐derived strains of <i>Pseudomonas aeruginosa</i>
International Forum of Allergy & Rhinology 2020cited by 18position: middledoi
<i>In‐vitro</i> evaluation of a ciprofloxacin and azithromycin sinus stent for <i>Pseudomonas aeruginosa</i> biofilms
International Forum of Allergy & Rhinology 2019cited by 29position: middledoi
Herbal dry extract BNO 1011 improves clinical and mucociliary parameters in a rabbit model of chronic rhinosinusitis
International Forum of Allergy & Rhinology 2019cited by 28position: middledoi
In‐vitro evaluation of a ciprofloxacin‐ and ivacaftor‐coated sinus stent against <i>Pseudomonas aeruginosa</i> biofilms
International Forum of Allergy & Rhinology 2019cited by 25position: middledoi
Controlled delivery of ciprofloxacin and ivacaftor via sinus stent in a preclinical model of <i>Pseudomonas</i> sinusitis
International Forum of Allergy & Rhinology 2019cited by 20position: middledoi
Ivacaftor, a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Enhances Ciprofloxacin Activity Against <i>Pseudomonas aeruginosa</i>
American Journal of Rhinology and Allergy 2018cited by 47position: middledoi
Resveratrol and ivacaftor are additive G551D CFTR‐channel potentiators: therapeutic implications for cystic fibrosis sinus disease
International Forum of Allergy & Rhinology 2018cited by 24position: middledoi
<scp>l</scp>‐Methionine anti‐biofilm activity against <i>Pseudomonas aeruginosa</i> is enhanced by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor
International Forum of Allergy & Rhinology 2018cited by 16position: middledoi
Submucosal gland mucus strand velocity is decreased in chronic rhinosinusitis
International Forum of Allergy & Rhinology 2018cited by 15position: middledoi
Characterization of primary rat nasal epithelial cultures in CFTR knockout rats as a model for CF sinus disease
The Laryngoscope 2017cited by 14position: middledoi
Chlorogenic Acid Activates CFTR‐Mediated Cl<sup>–</sup> Secretion in Mice and Humans
Otolaryngology 2015cited by 23position: middledoi
Cystic fibrosis transmembrane conductance regulator activation by the solvent ethanol: implications for topical drug delivery
International Forum of Allergy & Rhinology 2015cited by 17position: middledoi
Porcine nasal epithelial cultures for studies of cystic fibrosis sinusitis
International Forum of Allergy & Rhinology 2014cited by 14position: middledoi
Comparison of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Ciliary Beat Frequency Activation by the CFTR Modulators Genistein, VRT-532, and UC<sub>CF</sub>-152 in Primary Sinonasal Epithelial Cultures
JAMA Otolaryngology–Head & Neck Surgery 2013cited by 34position: middledoi
IP-10 Is a Potential Biomarker of Cystic Fibrosis Acute Pulmonary Exacerbations
PLoS ONE 2013cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bradford A. Woodworth · University of Alabama at Birmingham18 papers (2013–2023)Daniel Skinner · University of Alabama at Birmingham17 papers (2013–2023)Do‐Yeon Cho · University of Alabama at Birmingham15 papers (2015–2023)Dong‐Jin Lim · Kongju National University11 papers (2017–2023)Steven M. Rowe · University of Alabama at Birmingham9 papers (2013–2023)Jessica W. Grayson · University of Alabama at Birmingham9 papers (2018–2023)Calvin Mackey · University of Alabama at Birmingham7 papers (2017–2019)Justin P. McCormick · University of Alabama at Birmingham5 papers (2018–2019)Eric J. Sorscher · Emory University5 papers (2013–2021)Ahmed Lazrak · University of Alabama at Birmingham3 papers (2018–2023)Harrison M. Thompson · Indiana University Indianapolis3 papers (2019–2021)Sadis Matalon · University of Alabama at Birmingham3 papers (2018–2023)Jaime Garcia · University of Alabama at Birmingham3 papers (2018–2019)John G. Mclemore · University of Alabama at Birmingham3 papers (2019–2020)Jeffrey Brent Elder · University of Alabama at Birmingham3 papers (2019–2019)Christopher G. Weeks · University of Alabama at Birmingham3 papers (2018–2020)Catherine Banks · University of Alabama at Birmingham2 papers (2018–2018)Kiranya E. Tipirneni · University of Alabama at Birmingham2 papers (2017–2018)C. KOCH · University of Alabama at Birmingham2 papers (2019–2020)John M. West · University of Alabama at Birmingham2 papers (2019–2019)